| A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) (NCT00551213) | Merck Sharp & Dohme LLC | 2007-11-21 |
| Effectiveness Study of a Computer-Based Colorectal Cancer Screening Decision Aid (NCT00558233) | Wake Forest University Health Sciences | 2007-11-01 |
| Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer (NCT00898781) | Mayo Clinic | 2007-11-01 |
| Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer (NCT02475889) | The First People's Hospital of Changzhou | 2007-11-01 |
| Comparison of Bowel Preparation in Virtual Colonoscopy (VC) - Patient Experience (NCT00460837) | London North West Healthcare NHS Trust | 2007-11-01 |
| G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer (NCT00541125) | Federation Francophone de Cancerologie Digestive | 2007-11-01 |
| Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer (NCT00593060) | Jeffrey W. Clark, MD | 2007-11-01 |
| A New Method for Colorectal Cancer Screening: Colon Capsule Endoscopy Compared to Conventional Endoscopy (NCT00991003) | University Hospital, Basel, Switzerland | 2007-11-01 |
| Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery (NCT00541112) | UNICANCER | 2007-10-29 |
| A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g) (NCT00497497) | Genentech, Inc. | 2007-10-01 |
| Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer (NCT00873600) | Case Comprehensive Cancer Center | 2007-10-01 |
| Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer (NCT00569790) | Taiho Pharmaceutical Co., Ltd. | 2007-10-01 |
| Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer (NCT00569335) | Taiho Pharmaceutical Co., Ltd. | 2007-10-01 |
| Role of the MET Oncogene in Human Colorectal Cancer - A Translational Study (NCT02238821) | Fondazione del Piemonte per l'Oncologia | 2007-10-01 |
| Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer (NCT00625651) | Amgen | 2007-10-01 |
| The Active After Cancer Trial (AACT) (NCT00548236) | Dana-Farber Cancer Institute | 2007-10-01 |
| Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC) (NCT00569699) | Taiho Pharmaceutical Co., Ltd. | 2007-10-01 |
| Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer (NCT00553683) | Rutgers, The State University of New Jersey | 2007-10-01 |
| Comparison of Mechanical Bowel Preparation Versus Enema for Candidates to Colorectal Resection for Adenocarcinoma (NCT00940030) | European Institute of Oncology | 2007-10-01 |
| L19TNFα in Patients With Advanced Solid Tumors (NCT01253837) | Philogen S.p.A. | 2007-09-01 |
| Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin (NCT00884767) | Institut Cancerologie de l'Ouest | 2007-09-01 |
| Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung (NCT00557102) | National Cancer Institute, France | 2007-09-01 |
| Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer (NCT00550628) | Memorial Sloan Kettering Cancer Center | 2007-09-01 |
| Implementation Intentions to Promote Colon Cancer Screening in Rural Primary Care Practice (NCT00599378) | Kimberly Engelman, PhD | 2007-09-01 |
| Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) (NCT00625573) | Mt. Sinai Medical Center, Miami | 2007-09-01 |
| Minimally Invasive Surgery (MIS) Database for the Purpose of Research (NCT00535990) | University of California, San Diego | 2007-09-01 |
| Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations (NCT00476970) | Massachusetts General Hospital | 2007-09-01 |
| A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies (NCT00529984) | AlphaVax, Inc. | 2007-09-01 |
| Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer (NCT00522665) | Hoosier Cancer Research Network | 2007-08-01 |
| Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP) (NCT00525655) | M.D. Anderson Cancer Center | 2007-08-01 |
| Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer (NCT00524706) | Shizuoka Cancer Center | 2007-08-01 |
| Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers (NCT00684801) | Case Comprehensive Cancer Center | 2007-08-01 |
| Family Quality of Life Among Families With a Member Who is a Cancer Patient (NCT00544336) | Vanderbilt-Ingram Cancer Center | 2007-08-01 |
| DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D Supplements (NCT00550563) | Roswell Park Cancer Institute | 2007-08-01 |
| "Touch 2 Screen" Multi-media Colorectal Cancer Screening Intervention (NCT00594113) | Allen A. Greiner, MD, MPH | 2007-08-01 |
| Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer (NCT01212887) | Cancer Research UK | 2007-08-01 |
| Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab (NCT00897754) | ECOG-ACRIN Cancer Research Group | 2007-07-24 |
| Familial Colorectal Cancer Registry in Hispanics (NCT00927680) | University of Puerto Rico | 2007-07-01 |
| Metabolomics-Based Detection of Colorectal Cancer (NCT00507598) | Indiana University | 2007-07-01 |
| Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal Cancer (NCT00497107) | Iwate Medical University | 2007-07-01 |
| A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. (NCT00502671) | Hoffmann-La Roche | 2007-07-01 |
| Helping Women Stay Up-To-Date With Cancer Screening By Using a Prevention Care Manager or Usual Care (NCT00477646) | Dartmouth-Hitchcock Medical Center | 2007-07-01 |
| Use of Telehealth In-home Messaging to Improve GI (Gastrointestinal) Endoscopy Completion Rates (NCT00310362) | VA Office of Research and Development | 2007-07-01 |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer (NCT00640081) | Cheryl Pugh | 2007-07-01 |
| A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer (NCT00484939) | Hoffmann-La Roche | 2007-07-01 |
| Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581 (NCT00897429) | Alliance for Clinical Trials in Oncology | 2007-07-01 |
| A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese (NCT01289288) | Georgetown University | 2007-07-01 |
| A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. (NCT00642577) | Hoffmann-La Roche | 2007-07-01 |
| Improving Followup of Abnormal Colon Cancer Screening Tests (NCT00436137) | Harvard Vanguard Medical Associates | 2007-06-01 |
| Inflammatory Response After Colorectal Cancer Surgery (NCT01427647) | Universidad Complutense de Madrid | 2007-06-01 |
| Early Post-Op Recovery After Partial Large Bowel Resection (NCT00492193) | University Hospitals Cleveland Medical Center | 2007-06-01 |
| Combined Resection of Colorectal Metastases (NCT00606398) | University Health Network, Toronto | 2007-06-01 |
| Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy (NCT00503685) | Eli Lilly and Company | 2007-06-01 |
| Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer (NCT00450424) | Fox Chase Cancer Center | 2007-06-01 |
| Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer (NCT00575562) | Kyowa Kirin, Inc. | 2007-06-01 |
| Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement (NCT00537823) | Washington University School of Medicine | 2007-06-01 |
| Omega-3 Fatty Acids and Postoperative Complications After Colorectal Surgery (NCT00488904) | Aalborg University Hospital | 2007-06-01 |
| Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer (NCT00408772) | University of California, Davis | 2007-06-01 |
| Disseminated Tumour Cells (DTC) in Left Sided Colorectal Cancer (LSCC). (NCT03640572) | Jagiellonian University | 2007-06-01 |
| Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer (NCT00493857) | YM BioSciences | 2007-06-01 |
| Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery (NCT00513266) | Centre Hospitalier Universitaire Vaudois | 2007-06-01 |
| Peptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal Cancer (NCT00641615) | Kazuhiko Yoshimatsu | 2007-05-01 |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver (NCT00492999) | Memorial Sloan Kettering Cancer Center | 2007-05-01 |
| A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer (NCT00498407) | Clavis Pharma | 2007-05-01 |
| Studying a Quality of Life Questionnaire in Patients With Colorectal Cancer (NCT00564694) | National Cancer Institute (NCI) | 2007-05-01 |
| Pain in Cancer Survivors (NCT00581724) | Memorial Sloan Kettering Cancer Center | 2007-05-01 |
| A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer (NCT00478634) | Novartis Pharmaceuticals | 2007-05-01 |
| Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer (NCT00766142) | Institut Bergonié | 2007-05-01 |
| FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer (NCT00501410) | M.D. Anderson Cancer Center | 2007-04-23 |
| A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors (NCT00465725) | Poniard Pharmaceuticals | 2007-04-01 |
| Quality Improvement of Patient-Provider Communication For Colorectal Cancer Screening (NCT00324753) | VA Office of Research and Development | 2007-04-01 |
| Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer (NCT00689364) | Ministry of Science and Technology of the People´s Republic of China | 2007-04-01 |
| Trial of Patient Navigation-Activation (NCT00496678) | University of Rochester | 2007-04-01 |
| Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer. (NCT00436514) | Nantes University Hospital | 2007-04-01 |
| Ginger for Colorectal Cancer Prevention (NCT01344538) | University of Michigan | 2007-04-01 |
| Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer (NCT00544011) | Hopital Jean Minjoz | 2007-04-01 |
| ColoCare Study - Colorectal Cancer Cohort (NCT02328677) | University of Utah | 2007-03-01 |
| Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer (NCT00458809) | Wake Forest University Health Sciences | 2007-03-01 |
| Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities (NCT00453661) | M.D. Anderson Cancer Center | 2007-03-01 |
| A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer (NCT00437268) | Eli Lilly and Company | 2007-03-01 |
| Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery (NCT00559013) | Baxter Healthcare Corporation | 2007-03-01 |
| Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors (NCT00620295) | Masonic Cancer Center, University of Minnesota | 2007-03-01 |
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors (NCT00667641) | University of Medicine and Dentistry of New Jersey | 2007-03-01 |
| Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants (NCT00478309) | Fox Chase Cancer Center | 2007-03-01 |
| Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer (NCT00462501) | Memorial Sloan Kettering Cancer Center | 2007-03-01 |
| A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients (NCT00454116) | Genzyme, a Sanofi Company | 2007-03-01 |
| Study of XL281 in Adults With Solid Tumors (NCT00451880) | Exelixis | 2007-02-01 |
| Evaluation of NiTi Shape Memory End-to-End Compression Anastomosis Ring (CAR) for Compression Anastomosis in Anterior Resection (NCT00468416) | Tel-Aviv Sourasky Medical Center | 2007-02-01 |
| ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer (NCT00436072) | Dana-Farber Cancer Institute | 2007-02-01 |
| Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer (NCT00482222) | University of Southampton | 2007-02-01 |
| Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery (NCT00467142) | Institut Bergonié | 2007-01-23 |
| Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer (NCT00478010) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-01-19 |
| Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin With or Without Bevacizumab on Clinial Trial E-3200 (NCT00897819) | ECOG-ACRIN Cancer Research Group | 2007-01-03 |
| 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC) (NCT00433927) | PD Dr. med. Volker Heinemann | 2007-01-01 |
| TheraSphere for the Treatment of Liver Metastases (NCT00511862) | Boston Scientific Corporation | 2007-01-01 |
| Nutrition for Colorectal Cancer Patients and Neutrophil Functions (NCT01831310) | Kocaeli University | 2007-01-01 |
| Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases (NCT01677728) | Xu jianmin | 2007-01-01 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer (NCT00628810) | Federation Francophone de Cancerologie Digestive | 2007-01-01 |
| Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer (NCT00438737) | European Organisation for Research and Treatment of Cancer - EORTC | 2007-01-01 |
| Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan (NCT00496704) | Yonsei University | 2007-01-01 |